Business

Patrons Sari and Peter Melendez enjoy lunch at Katz’s Delicatessen, the famous deli founded in 1888, on the first day of the return to indoor dining for New York City, during the coronavirus disease (COVID-19) pandemic, in New York, February 12, 2021. Brendan McDermid | Reuters Easing mask mandates and reopening restaurants have led to
0 Comments
Louis Conforti, CEO of the Washington Prime Group, on CNBC’s Mad Money. Source: CNBC The U.S. shopping mall owner Washington Prime Group is preparing to potentially file for Chapter 11 bankruptcy protection, with time running thin before the company defaults after it skipped an interest payment on its debt, Bloomberg reported Thursday. Last month, Washington
0 Comments
Joe Biden can end the man-made contribution to global warming completely, says Howard Bloom, founder and chair of the Space Development Steering Committee. President Biden can end that man-made contribution by harvesting solar power in space and transmitting it to earth, a process called space solar power. President Biden has committed to reviving the American
0 Comments
Gary Collis of Bunker Hill, West Virginia, receives his boost dose at a coronavirus disease (COVID-19) community vaccination event, as the vaccination rate in West Virginia ranks among highest in world, in Martinsburg, February 25, 2021. Kevin Lamarque | Reuters Johnson & Johnson‘s Covid-19 vaccine can be used as a substitute for a second jab
0 Comments
Johnson & Johnson Coronavirus vaccine illustration Dado Ruvic | Reuters An advisory panel to the Centers for Disease Control and Prevention voted unanimously Sunday to recommend the use of Johnson & Johnson‘s one-shot Covid-19 vaccine as the federal government prepares to ship out millions of doses this week. Once CDC Director Dr. Rochelle Walensky accepts
0 Comments
A key Food and Drug Administration advisory panel on Friday unanimously backed Johnson & Johnson‘s single-shot coronavirus vaccine for emergency use, a critical step paving the way to distribute a third preventative treatment in the U.S. next week. The nonbinding decision, which was adopted 22-0, by the FDA’s Vaccines and Related Biological Products Advisory Committee
0 Comments